XRCC4 codon 247*A and XRCC4 promoter-1394*T related genotypes but not XRCC4 intron 3 gene polymorphism are associated with higher susceptibility for endometriosis

被引:20
作者
Hsieh, Yao-Yuan [1 ,2 ]
Bau, Da-Tian [3 ,4 ]
Chang, Chi-Chen [1 ]
Tsai, Chang-Hai [3 ,5 ]
Chen, Chih-Ping [6 ]
Tsai, Fuu-Jen [4 ]
机构
[1] China Med Univ Hosp, Dept Obstet & Gynaecol, Taichung, Taiwan
[2] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu, Taiwan
[3] China Med Univ Hosp, Dept Med Res, Taichung, Taiwan
[4] China Med Univ, Grad Inst Chinese Med Sci, Taichung, Taiwan
[5] Univ Asia, Taichung, Taiwan
[6] Mackay Mem Hosp, Dept Obstet & Gynaecol, Taipei, Taiwan
关键词
endometriosis; gene repair; polymorphism; SNP; XRCC4;
D O I
10.1002/mrd.20829
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
DNA repair systems act to maintain genome integrity in the face of replication errors, environmental insults, and the cumulative effects of age. Genetic variants in DNA repair genes such as X-ray repair cross-complementing group 4 (XRCC4) might influence the ability to repair damaged DNA. Herein we aimed to investigate whether some XRCC4-related polymorphisms were associated with endometriosis susceptibility. Women were divided: (1) severe endometriosis (rAFS stage IV, n = 136) and (2) nonendometriosis groups (n = 112). The polymorphisms of XRCC4 codon 247, XRCC4 promoter - 1394, and XRCC4 intron 3 insertion/deletion (I/D) polymorphism were amplified by PCR and detected by electrophoresis after restriction enzyme (BBS I, Hinc II) digestions. Genotypes and allelic frequencies in both groups were compared. We observed that XRCC4 codon 247*A and XRCC4 promoter - 1394*T related genotypes, but not XRCC4 intron 3 I/D polymorphism, are associated with higher susceptibility for endometriosis. Distributions of XRCC4 codon 247*C homozygote/heterozygote/A homozygote, and C/A allele in both groups were: (1) 89/9.5/1.5% and 93.7/6.3%; (2) 97.3/2.7/0%, and 98.7/1.3% (P < 0.05). Proportions of XRCC4 promoter -1394*T homozygote/heterozygote/G homozygote and T/Gallelein both groups were: (1) 94.1/5.2/0.7% and 96.7/3.3%, and (2) 79.4/17.9/2.7% and 88.4/11.6% (P < 0.005). Proportions of XRCC4*1 homozygote/heterozygote/D homozygote and A/C allele in both groups were: (1) 67.6/30.9/1.5% and 83.2/16.8%, and (2) 70.5/24.1/5.4% and 82.6/17.4% (nondifference). We conclude that XRCC4 codon 247*A and XRCC4 promoter -1394*T related genotypes and alleles, but not XRCC4 intron 3 I/D polymorphism, might be associated with endometriosis susceptibilities and pathogenesis.
引用
收藏
页码:946 / 951
页数:6
相关论文
共 34 条
  • [1] Patterns of loss of heterozygosity at 10q23.3 and microsatellite instability in endometriosis, atypical endometriosis, and ovarian carcinoma arising in association with endometriosis
    Ali-Fehmi, Rouba
    Khalifeh, Ibrahim
    Bandyopadhyay, Sudeshna
    Lawrence, W. Dwayne
    Silva, Elvio
    Liao, Dezhong
    Sarkar, Fazlul H.
    Munkarah, Adnan R.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2006, 25 (03) : 223 - 229
  • [2] A role for XRCC4 in age at diagnosis and breast cancer risk
    Allen-Brady, Kristina
    Cannon-Albright, Lisa A.
    Neuhausen, Susan L.
    Camp, Nicola J.
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2006, 15 (07) : 1306 - 1310
  • [3] [Anonymous], 1985, Fertil Steril, V43, P351
  • [4] Markers of DNA repair and susceptibility to cancer in humans: An epidemiologic review
    Berwick, M
    Vineis, P
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (11): : 874 - 897
  • [5] An intronic polymorphism associated with increased XRCC1 expression, reduced apoptosis and familial breast cancer
    Bu, Dawei
    Tomlinson, Gail
    Lewis, Cheryl M.
    Zhang, Cindy
    Kildebeck, Eric
    Euhus, David M.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2006, 99 (03) : 257 - 265
  • [6] The BRCA1 suppressor hypothesis: An explanation for the tissue-specific tumor development in BRCA1 patients
    Elledge, SJ
    Amon, A
    [J]. CANCER CELL, 2002, 1 (02) : 129 - 132
  • [7] Antiangiogenic therapies in endometriosis
    Ferrero, S.
    Ragni, N.
    Remorgida, V.
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2006, 149 (02) : 133 - 135
  • [8] Fukunaga M, 1998, MODERN PATHOL, V11, P784
  • [9] Polymorphisms in DNA double-strand break repair genes and risk of breast cancer:: two population-based studies in USA and Poland, and meta-analyses
    García-Closas, M
    Egan, KM
    Newcomb, PA
    Brinton, LA
    Titus-Ernstoff, L
    Chanock, S
    Welch, R
    Lissowska, J
    Peplonska, B
    Szeszenia-Dabrowska, N
    Zatonski, W
    Bardin-Mikolajczak, A
    Struewing, JP
    [J]. HUMAN GENETICS, 2006, 119 (04) : 376 - 388
  • [10] Goumenou AG, 2000, INT J MOL MED, V6, P667